Case Background
Case Report
Name: Bear
Age: 13 years old
Clinical Presentation
Body Weight: 15.2kg
Nationality: USA
Date of Operation: 2021.1.27
MMVD: stage C
Procedure & Outcome
Full Operation Record
The "Bear" in the ICU after the operation
Follow-up & Insights
The "Bear" who was discharged from the hospital, went for a walk with the owner~
Last year, Hong Yu's related news was posted on the website of the school of veterinary medicine of Colorado State University.
It is pointed out that:
“This was the first successful beating-heart mitral valve repair in a dog with severe mitral regurgitation,” Orton said.
Discussion
The need for this type of medical breakthrough in the veterinary realm is huge, said Orton, because mitral regurgitation is the most common heart disease in older dogs, affecting 7% of all canines.
Veterinarians at CSU have worked for nearly 10 years to find new ways to treat this condition.
“We’ve been looking for ways to treat this extremely common condition, rather than just treating their heart failure medically until they die,” Orton said.
Heart tips
Canine mitral regurgitation is very common in small dogs in the elderly, with an incidence rate of 20-30%. The occurrence of the disease is related to breed, age and gender. The age of sick dogs is mostly distributed in 5 ~ l 6 years old. The disease rate increases with age, mostly in small dogs and male dogs.
Canine mitral regurgitation has characteristic night cough, night asthma, weakness, exercise intolerance or fatigue after exercise and excitement, prolonged recovery time, severe purple tongue color, syncope and so on. The survival time of dogs with severe mitral regurgitation disease is only 3-6 months.
The control effect of traditional drugs is general, which can only alleviate symptoms, can not be cured, and the condition will still gradually worsen. The monthly drug cost ranges from 2000 to 4000 yuan. Or valve replacement. The operation is difficult, high risk, high mortality and expensive. At present, only a few teams in the world have completed individual cases, which can not be popularized in a large area.
Shanghai Hongyu medical v-clamp minimally invasive surgery has the advantages of high safety, small trauma and fast recovery. It does not need cardiac arrest and cardiopulmonary bypass. It cuts a 2-3cm incision in the precordial area, punctures the heart and sends instruments to complete mitral valve repair, reduces mitral regurgitation, and provides a new technical scheme for the treatment of canine mitral regurgitation.
Closing Notes
HONG YU
